Methuselah Pharmaceuticals

Methuselah Pharmaceuticals is a private U.S. biotech company formed as a wholly owned subsidiary of AntiCancer to commercialize methioninase-based therapeutics. Publicly available information indicates the company is focused on oral methioninase, an enzyme-based approach intended to deplete methionine and exploit methionine dependence in cancer and potentially other age-related or metabolic conditions. The company appears to be very early stage, with limited disclosed pipeline, financing, partnership, and operating information. Its known footprint is centered in San Diego, California, and available records show it remains an active legal entity.